ProfileGDS4718 / 1553449_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 35% 35% 25% 45% 21% 18% 11% 46% 36% 42% 43% 13% 25% 15% 13% 39% 25% 13% 15% 15% 50% 32% 34% 28% 34% 20% 27% 13% 29% 17% 17% 18% 34% 45% 16% 15% 20% 39% 29% 25% 43% 12% 12% 15% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.7902635
GSM549102patient 115, normal, homogenized [OPG study]4.7935735
GSM549104patient 119, normal, homogenized [OPG study]4.3122925
GSM549108patient 138, normal, homogenized [OPG study]5.3062845
GSM549119patient 077, normal, homogenized [OPG study]4.1965621
GSM549133patient 032, cancer, homogenized [OPG study]4.0251918
GSM549139patient 042, cancer, homogenized [OPG study]3.7959211
GSM549099patient 107, normal, homogenized [OPG study]5.3310246
GSM549109patient 139, normal, homogenized [OPG study]4.8027436
GSM549110patient 046, normal, homogenized [OPG study]5.0994442
GSM549114patient 063, normal, homogenized [OPG study]5.1029543
GSM549122patient 082, normal, homogenized [OPG study]3.9069313
GSM549134patient 033, cancer, homogenized [OPG study]4.3481825
GSM549136patient 036, cancer, homogenized [OPG study]3.9207215
GSM549140patient 044, cancer, homogenized [OPG study]3.8674713
GSM549111patient 047, normal, homogenized [OPG study]4.9016139
GSM549113patient 057, normal, homogenized [OPG study]4.3010725
GSM549132patient 031, cancer, homogenized [OPG study]3.8683913
GSM549137patient 038, cancer, homogenized [OPG study]3.9682715
GSM549142patient 047, cancer, homogenized [OPG study]4.0340815
GSM549100patient 110, normal, homogenized [OPG study]5.5089350
GSM549107patient 135, normal, homogenized [OPG study]4.6045432
GSM549115patient 068, normal, homogenized [OPG study]4.6406234
GSM549116patient 072, normal, homogenized [OPG study]4.4452128
GSM549120patient 078, normal, homogenized [OPG study]4.7033434
GSM549131patient 030, cancer, homogenized [OPG study]4.0862820
GSM549118patient 074, normal, homogenized [OPG study]4.4071727
GSM549129patient 027, cancer, homogenized [OPG study]3.8913513
GSM549123patient 088, normal, homogenized [OPG study]4.5007829
GSM549124patient 006, cancer, homogenized [OPG study]4.0893717
GSM549126patient 015, cancer, homogenized [OPG study]4.0109217
GSM549128patient 025, cancer, homogenized [OPG study]4.0368218
GSM549103patient 117, normal, homogenized [OPG study]4.7661334
GSM549117patient 073, normal, homogenized [OPG study]5.222845
GSM549138patient 041, cancer, homogenized [OPG study]3.9734816
GSM549141patient 045, cancer, homogenized [OPG study]3.9207215
GSM549130patient 028, cancer, homogenized [OPG study]4.1680920
GSM549101patient 111, normal, homogenized [OPG study]4.9835239
GSM549105patient 128, normal, homogenized [OPG study]4.5023329
GSM549106patient 134, normal, homogenized [OPG study]4.303425
GSM549112patient 048, normal, homogenized [OPG study]5.1219243
GSM549125patient 011, cancer, homogenized [OPG study]3.8500812
GSM549127patient 024, cancer, homogenized [OPG study]3.8441912
GSM549135patient 035, cancer, homogenized [OPG study]3.9318615